by Avi Kapoor | Mar 17, 2026 | General
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst...
by Vandana Singh | Mar 17, 2026 | General
A federal court has signaled that recent U.S. government actions altering vaccine recommendations and restructuring a key advisory panel likely violated federal law. In January, the Trump administration announced that it would be changing the federal vaccine schedule....
by Avi Kapoor | Mar 17, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Morgan Stanley analyst Bob Huang upgraded Lemonade Inc...
by Vandana Singh | Mar 17, 2026 | General
Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) shares are down during Tuesday’s premarket session following the Monday announcement of topline results from its EMANATE trial. EMANATE was a Phase 3 trial designed to evaluate the efficacy and safety of setmelanotide in...
by Lekha Gupta | Mar 17, 2026 | General
CrowdStrike (NASDAQ:CRWD) shares are down during Tuesday’s premarket session. On Monday, the company announced an expanded collaboration with NVIDIA Corporation (NASDAQ:NVDA) to enhance its Agentic Managed Detection and Response (MDR) capabilities. The collaboration...
Recent Comments